MetLife, Inc. (MET) Key Metrics
MET valuation today
Trailing 12 months · as of October 18, 2026- Market cap
- $64.03B
- Enterprise value
- $81.88B
- P/E (TTM)
- 19.3 10-yr median 12.1
- Forward P/E
- 10.5
- PEG ratio
- 0.51
- Price / sales
- 0.8 10-yr median 0.8
- Price / book
- 2.2 10-yr median 0.9
- EV / EBITDA
- —
- Dividend yield
- 2.35% $2.37 a year
- Beta
- 0.78
MET key metrics, 2016–2025
Fiscal year ended December 31, 2025 · U.S. dollarsMET valuation Price multiples at each fiscal year-end price.
MET returns How much profit the business earns on the capital it uses.
MET per-share figures Results divided by the shares outstanding at year-end.
MET financial health Debt, liquidity and how easily interest is covered.
MET efficiency & capital use Working capital cycle and where the cash goes.
MET valuation history
MET returns on capital
Net income (ROE, ROA) or after-tax operating income (ROIC) divided by the average of the opening and closing balance.
MET debt vs cash
Debt includes short- and long-term borrowings and, where reported, lease liabilities.
MET cash returned to shareholders
MET price vs earnings per share
MET key metrics
2016–2025| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Valuation | ||||||||||
| Market capitalization | $52.49B | $58.22B | $50.42B | $58.54B | $54.33B | $42.87B | $48.14B | $41.63B | $52.76B | $52.62B |
| Enterprise value | −$52.66B | −$31.84B | −$247.59B | −$236.80B | −$295.74B | −$317.48B | −$283.28B | −$260.15B | −$254.43B | −$239.16B |
| P/E ratio | 15.5 | 13.2 | 32.0 | 11.1 | 7.9 | 7.9 | 8.2 | 8.1 | 13.2 | 61.9 |
| Price / sales | 0.7 | 0.8 | 0.7 | 0.9 | 0.9 | 0.6 | 0.7 | 0.6 | 0.8 | 0.9 |
| Price / book | 1.8 | 2.1 | 1.7 | 2.0 | 0.8 | 0.6 | 0.7 | 0.8 | 0.9 | 0.8 |
| Price / free cash flow | 2.9 | 3.9 | 3.5 | 4.4 | 3.2 | 5.8 | 5.9 | 4.4 | 4.1 | 3.6 |
| Price / operating cash flow | 2.9 | 3.9 | 3.5 | 4.4 | 4.3 | 3.7 | 3.5 | 4.4 | 4.1 | 3.6 |
| EV / sales | -0.7 | -0.4 | -3.7 | -3.5 | -4.7 | -4.7 | -4.1 | -3.8 | -4.1 | -4.0 |
| Earnings yield | 6.4% | 7.6% | 3.1% | 9.0% | 12.6% | 12.6% | 12.3% | 12.3% | 7.6% | 1.6% |
| Free cash flow yield | 34.5% | 26.0% | 28.3% | 22.6% | 31.2% | 17.2% | 16.9% | 22.9% | 24.1% | 27.9% |
| Dividend yield | 3.2% | 3.0% | 3.5% | 3.0% | 3.4% | 4.3% | 3.8% | 4.4% | 3.4% | 3.5% |
| Shareholder yield (dividends + buybacks) | 10.6% | 8.5% | 9.7% | 8.7% | 12.2% | 9.4% | 8.5% | 14.0% | 9.0% | 4.2% |
| Share price at fiscal year-end | $78.94 | $81.88 | $66.13 | $72.37 | $62.49 | $46.95 | $50.97 | $41.06 | $50.56 | $48.03 |
| Per share | ||||||||||
| Revenue per share | $115.92 | $99.82 | $88.81 | $84.02 | $72.88 | $74.34 | $73.72 | $67.01 | $59.71 | $55.25 |
| Earnings per share | $5.08 | $6.22 | $2.07 | $6.53 | $7.88 | $5.92 | $6.25 | $5.05 | $3.84 | $0.78 |
| Operating cash flow per share | $27.23 | $21.26 | $18.70 | $16.32 | $14.49 | $12.75 | $14.60 | $9.40 | $12.19 | $13.38 |
| Free cash flow per share | $27.23 | $21.26 | $18.70 | $16.32 | $19.50 | $8.07 | $8.61 | $9.40 | $12.19 | $13.38 |
| Cash per share | $188.49 | $152.98 | $415.56 | $387.34 | $422.70 | $414.49 | $368.77 | $313.66 | $312.86 | $284.46 |
| Book value per share | $42.71 | $38.60 | $39.37 | $36.94 | $77.62 | $81.64 | $70.04 | $52.02 | $56.23 | $61.64 |
| Tangible book value per share | −$3.49 | −$1.52 | $0.82 | $1.15 | $48.18 | $50.11 | $39.99 | $22.82 | $28.18 | $36.07 |
| Dividends per share | $2.56 | $2.43 | $2.31 | $2.20 | $2.12 | $2.04 | $1.93 | $1.79 | $1.74 | $1.68 |
| Capex per share | $0.00 | $0.00 | $1.53 | $0.00 | $5.01 | $4.67 | $5.99 | $6.97 | $4.37 | $7.79 |
| Debt per share | $30.35 | $26.32 | $24.69 | $22.23 | $20.05 | $19.87 | $17.84 | $16.02 | $18.50 | $18.12 |
| Shares outstanding | 665.0M | 711.1M | 762.4M | 808.9M | 869.4M | 913.2M | 944.4M | 1.01B | 1.04B | 1.10B |
| Change in shares outstanding | −6.5% | −6.7% | −5.7% | −7.0% | −4.8% | −3.3% | −6.9% | −2.8% | −4.7% | −2.9% |
| Returns & profitability | ||||||||||
| Return on equity (ROE) | 12.1% | 15.4% | 5.3% | 10.9% | 9.7% | 7.7% | 9.9% | 9.2% | 6.4% | 1.3% |
| Return on assets (ROA) | 0.5% | 0.6% | 0.2% | 0.7% | 0.9% | 0.7% | 0.8% | 0.7% | 0.5% | 0.1% |
| Return on tangible assets | 0.5% | 0.7% | 0.2% | 0.8% | 0.9% | 0.7% | 0.8% | 0.8% | 0.6% | 0.1% |
| Free cash flow margin | 23.5% | 21.3% | 21.1% | 19.4% | 26.8% | 10.9% | 11.7% | 14.0% | 20.4% | 24.2% |
| Income quality (OCF / net income) | 5.36 | 3.42 | 9.04 | 2.50 | 1.84 | 2.15 | 2.34 | 1.86 | 3.17 | 17.25 |
| Financial health | ||||||||||
| Total debt | $20.18B | $18.71B | $18.83B | $17.98B | $17.43B | $18.15B | $16.85B | $16.24B | $19.31B | $19.85B |
| Cash & short-term investments | $125.34B | $108.78B | $316.83B | $313.32B | $367.50B | $378.51B | $348.27B | $318.02B | $326.50B | $311.63B |
| Net debt | −$105.15B | −$90.07B | −$298.00B | −$295.34B | −$350.07B | −$360.36B | −$331.42B | −$301.78B | −$307.19B | −$291.78B |
| Debt / equity | 0.71 | 0.68 | 0.63 | 0.60 | 0.26 | 0.24 | 0.25 | 0.31 | 0.33 | 0.29 |
| Debt / assets | 0.03 | 0.03 | 0.03 | 0.03 | 0.02 | 0.02 | 0.02 | 0.02 | 0.03 | 0.02 |
| Net debt / EBITDA | −16.24 | −12.22 | −75.92 | −37.03 | −34.55 | −42.60 | −39.55 | −37.46 | −56.26 | −47.91 |
| Current ratio | 0.65 | 0.55 | 1.36 | 1.34 | 1.47 | — | — | 0.92 | 0.80 | 0.05 |
| Quick ratio | 0.65 | 0.55 | 1.77 | 1.34 | 1.68 | — | — | 0.97 | 0.80 | 0.05 |
| Interest coverage | 4.4 | 6.4 | 2.1 | 6.8 | 9.3 | 7.6 | 7.1 | 5.6 | 3.1 | 3.7 |
| Working capital | −$96.55B | −$115.03B | $93.04B | $84.41B | $124.84B | $395.99B | $368.48B | −$2.16B | −$5.42B | −$773.90B |
| Invested capital | −$76.76B | −$62.62B | −$267.99B | −$265.46B | −$282.58B | −$285.80B | −$265.27B | −$249.04B | −$248.52B | −$224.25B |
| Tangible asset value | −$1.80B | −$825.0M | $866.0M | $1.18B | $42.15B | $46.02B | $38.01B | $23.36B | $29.60B | $39.68B |
| Net current asset value | −$536.65B | −$506.71B | −$306.71B | −$297.46B | −$303.94B | −$323.95B | −$305.37B | −$611.24B | −$639.93B | −$793.12B |
| Graham number | $69.88 | $73.52 | $42.82 | $73.68 | $117.35 | $104.29 | $99.21 | $76.90 | $69.72 | $32.80 |
| Graham net-net per share | −$827.45 | −$724.62 | −$481.77 | −$374.58 | −$387.34 | −$392.43 | −$361.78 | −$298.40 | −$307.31 | −$463.55 |
| Capital allocation | ||||||||||
| Dividends paid | $1.70B | $1.73B | $1.76B | $1.78B | $1.84B | $1.86B | $1.82B | $1.82B | $1.82B | $1.84B |
| Share buybacks (net) | $3.88B | $3.21B | $3.10B | $3.33B | $4.80B | $2.15B | $2.29B | $3.99B | $2.93B | $372.0M |
| Dividend payout ratio | 50.4% | 39.0% | 111.8% | 33.7% | 26.9% | 34.4% | 30.9% | 35.5% | 45.4% | 216.4% |
| Dividends + buybacks / free cash flow | 30.9% | 32.6% | 34.1% | 38.7% | 39.2% | 54.5% | 50.5% | 61.0% | 37.3% | 15.1% |
| Capex / revenue | 0.0% | 0.0% | 1.7% | 0.0% | 6.9% | 6.3% | 8.1% | 10.4% | 7.3% | 14.1% |
| Capex / operating cash flow | 0.0% | 0.0% | 8.2% | 0.0% | 34.6% | 36.7% | 41.0% | 74.2% | 35.9% | 58.2% |
| Capex / depreciation | 0.00 | 0.00 | 1.63 | 0.00 | 6.28 | 6.90 | 8.97 | 11.26 | 5.74 | 13.09 |
| Stock-based compensation / revenue | — | — | 0.3% | 0.3% | 0.3% | 0.2% | 0.2% | 0.1% | 0.2% | 0.2% |
| SG&A / revenue | 10.9% | 8.4% | 9.1% | 8.7% | 9.1% | 8.5% | 9.4% | 9.5% | 10.8% | 11.8% |
| Efficiency | ||||||||||
| Days sales outstanding | 209.6 | 174.9 | 150.8 | 114.6 | 110.6 | 103.0 | 105.1 | 102.3 | 99.3 | 115.6 |
| Days of inventory on hand | — | — | -755.2 | — | -452.0 | -425.7 | -218.0 | -5.0 | — | — |
| Days payables outstanding | — | — | — | 85.5 | 9.0 | 1.7 | 2.7 | 2.6 | 71.3 | 128.0 |
| Cash conversion cycle (days) | — | — | — | 29.2 | -350.5 | -324.4 | -115.6 | 94.6 | 27.9 | -12.5 |
| Receivables turnover | 1.74 | 2.09 | 2.42 | 3.18 | 3.30 | 3.54 | 3.47 | 3.57 | 3.68 | 3.16 |
| Payables turnover | — | — | — | 4.27 | 40.66 | 213.08 | 132.91 | 138.41 | 5.12 | 2.85 |
| Asset turnover | 0.11 | 0.10 | 0.10 | 0.10 | 0.08 | 0.09 | 0.10 | 0.10 | 0.08 | 0.07 |
| Average receivables | $44.26B | $34.02B | $27.98B | $21.34B | $19.19B | $19.16B | $20.04B | $19.03B | $16.94B | $19.16B |
| Average payables | — | — | — | $11.48B | $1.14B | $246.0M | $402.0M | $376.0M | $9.55B | $16.34B |
| Average inventory | — | — | −$104.32B | — | −$57.63B | −$61.13B | −$31.91B | −$720.0M | $0 | $0 |
| Intangibles / total assets | 4.1% | 4.2% | 4.3% | 4.4% | 3.4% | 3.6% | 3.8% | 4.3% | 4.1% | 3.1% |
Computed from MET's annual financial statements (latest annual report filed February 19, 2026) and the closing share price on each fiscal year-end, adjusted for stock splits. Figures in U.S. dollars; data from EODHD. Averages use the opening and closing balance of each year.
MET valuation and financial ratios
At the end of fiscal 2025 (December 31, 2025), MetLife traded at 15.5 times earnings, against a 10-year median of 12.1. Based on the latest twelve months, the trailing P/E is 19.3 and the forward P/E is 10.5. MetLife earned a return on equity of 12.1% in fiscal 2025. It ended the year with $20.2 billion of debt and $125.3 billion in cash and short-term investments, a net cash position of $105.2 billion. It returned $5.6 billion to shareholders: $1.7 billion in dividends and $3.9 billion in share buybacks, 31% of free cash flow. The share count fell 39.3% from 1.10B to 665.0M over 9 years.
See the MET income statement, the MET chart for price history, or the MET stock overview for the latest quote and news.
MET key metrics FAQ
What is MetLife's P/E ratio?
MetLife's trailing P/E ratio is 19.3 based on the last twelve months of earnings (as of October 18, 2026), and its forward P/E is 10.5. At the end of fiscal 2025 it was 15.5, compared with a 10-year median of 12.1.
What is MetLife's return on equity?
MetLife's return on equity (ROE) was 12.1% in fiscal 2025: net income of $3.4 billion on average shareholders' equity of $27.9 billion.
How much debt does MetLife have?
MetLife had total debt of $20.2 billion at the end of fiscal 2025, a debt-to-equity ratio of 0.71 and more cash than debt.
What is MetLife's dividend yield?
MetLife's forward dividend yield is 2.35%. MetLife paid $1.7 billion in dividends in fiscal 2025 ($2.56 per share), a payout ratio of 50.4%.
Does MetLife buy back its shares?
Yes. MetLife spent $3.9 billion on net share repurchases in fiscal 2025 Shares outstanding changed −6.5% over the year, to 665.0M..
What is MetLife's free cash flow yield?
MetLife generated $18.1 billion of free cash flow in fiscal 2025, a free cash flow yield of 34.5% on its market value at year-end ($52.5 billion).
What is MetLife's current ratio?
MetLife's current ratio was 0.65 at the end of fiscal 2025: current assets were 0.65 times current liabilities.